Whittaker Clark Daniels Bankruptcy

In re Whittaker Clark & Daniels
Court	U.S. Court of Appeals, Third Circuit (precedential)
Dockets	Nos. 24-2210 & 24-2211 (consolidated); No. 25-1044
Decided	April 27, 2026
Panel	Ambro (auth.), Krause, Matey
Appellants	Peter Protopapas (Receiver); Official Committee of Talc Claimants
On appeal from	D.N.J. (Judge Quraishi); Bankr. D.N.J. (Judge Kaplan)
Disposition	Affirmed
Key holding	Product-line successor-liability claims are property of the bankruptcy estate (11 U.S.C. § 541)

Executive Summary

In re Whittaker Clark & Daniels, Inc. is a precedential decision issued by the United States Court of Appeals for the Third Circuit on April 27, 2026, in consolidated appeals Nos. 24-2210, 24-2211, and 25-1044. The case arose from the Chapter 11 bankruptcy of Whittaker Clark & Daniels — a company the court described as having processed and distributed "asbestos-laden talc" and that became the target of roughly 2,700 personal-injury claims, many for mesothelioma. The ruling is one of the most consequential recent appellate decisions for how victims of talc-asbestos exposure recover when a talc supplier enters bankruptcy.

The court resolved two questions. First, it held that Whittaker's board retained lawful authority to file for bankruptcy despite a South Carolina receivership, and clarified that an improperly filed petition is "cause" to dismiss but is not a jurisdictional defect. Second — and more consequentially — it held that the "product-line" successor-liability claims that talc claimants sought to pursue against Whittaker's asset-buyer, Brenntag, are property of the bankruptcy estate under 11 U.S.C. § 541, not personal claims belonging to individual plaintiffs.

The practical effect is that a $535 million settlement Brenntag agreed to pay can move forward, with the proceeds flowing into the bankruptcy estate for distribution to creditors — a large, preserved recovery pool for asbestos victims — rather than to individual plaintiffs suing piecemeal. For patients and families, the decision changes who controls the claims and how compensation is distributed; it underscores why experienced asbestos counsel matters when a defendant's liabilities are routed through a bankruptcy. Speak with a mesothelioma attorney to understand how a ruling like this affects your options.

At a Glance

In re Whittaker Clark & Daniels at a glance:

• Precedential Third Circuit ruling, April 27, 2026 — consolidated Nos. 24-2210, 24-2211, 25-1044; authored by Judge Ambro (with Judges Krause and Matey).
• ~2,700 asbestos/mesothelioma claimants had asserted personal-injury claims against the Debtors over asbestos-contaminated talc.
• $535 million Brenntag settlement preserved — the ruling clears the way for the settlement to fund the estate for distribution to claimants.
• Product-line successor-liability claims = property of the estate under 11 U.S.C. § 541(a)(1), following In re Emoral.
• Trustee/debtor-in-possession holds exclusive authority over those estate claims under 11 U.S.C. § 323 — individuals can no longer prosecute them independently.
• Improperly filed petition is "cause" to dismiss, not jurisdictional — resolving a previously unsettled question and aligning with the Second and Ninth Circuits.
• "Plead-around" rejected — claimants cannot recharacterize estate claims as personal ones to escape the bankruptcy, citing In re Tronox.
• Purdue Pharma objection preserved — the court called the third-party-release argument premature, leaving it open for the plan-confirmation stage.
• Product-line theory is a minority rule — recognized in only a few states (New Jersey and California named); its ultimate reach was left unresolved.

Key Facts

Item	Detail (Source)
Case	In re Whittaker Clark & Daniels, Inc., 3d Cir. Nos. 24-2210 & 24-2211, No. 25-1044 (Apr. 27, 2026), precedential
Lower courts	Bankr. D.N.J. (Judge Kaplan), In re Whittaker, Clark & Daniels, 663 B.R. 1 (Bankr. D.N.J. 2024); D.N.J. (Judge Quraishi) affirmed
Claimants	~2,700 asbestos personal-injury claimants; environmental claims spanning at least 14 states
Representative verdict	Sarah Plant — $29 million (South Carolina, March 2023), mesothelioma from asbestos-contaminated Whittaker talc
2004 asset sale	Whittaker, Brilliant and Soco sold operating assets to Brenntag North America for ~$200 million; pre-sale asbestos/environmental liabilities excluded
Settlement	Brenntag to pay ~$535 million to the estate to release successor-liability claims
Controlling statutes	11 U.S.C. § 541 (property of the estate); § 323 (trustee authority); § 1112(b) (cause to dismiss); § 158(d)(2) (direct appeal)

What was the Whittaker Clark & Daniels case about?

Whittaker Clark & Daniels, Inc. processed, stored, and distributed industrial minerals, including talc the court described as "asbestos-laden." Over decades, that talc generated thousands of personal-injury claims. By the time of the bankruptcy, roughly 2,700 plaintiffs had alleged asbestos-related injuries — including mesothelioma — from Whittaker's talc, and environmental claims reached across at least fourteen states. One representative case: Sarah Plant, who was diagnosed with mesothelioma after exposure to asbestos-contaminated Whittaker talc, won a $29 million jury verdict in South Carolina in March 2023.

In 2004, Whittaker and affiliated entities (Brilliant National Services and Soco West) sold substantially all of their operating assets to subsidiaries of Brenntag North America for about $200 million. Brenntag's purchase agreement expressly excluded pre-sale asbestos and environmental liabilities; Whittaker agreed to indemnify Brenntag for those claims and continued on as a shell entity. Through later transactions, National Indemnity Company — a Berkshire Hathaway subsidiary — came to backstop certain successor-liability exposure tied to Brenntag, which is why Berkshire-affiliated parties participated in the appeal. With more than a thousand asbestos claims still pending, the Debtors filed for Chapter 11 in the District of New Jersey in 2023 and negotiated a $535 million settlement with Brenntag — a deal that could not close until courts decided who actually controlled the successor-liability claims.

How did the case reach the Third Circuit?

The dispute traveled a layered path:

• South Carolina receivership. A state court appointed Peter Protopapas as receiver over Whittaker. When Whittaker's board filed for bankruptcy over the receiver's objection, Protopapas moved to dismiss, arguing the board lacked authority to file.
• U.S. Bankruptcy Court, District of New Jersey (Judge Michael B. Kaplan). The court denied the motion to dismiss and, on summary judgment, held that the product-line successor-liability claims against Brenntag are property of the estate under 11 U.S.C. § 541, following In re Emoral. It certified the questions for direct appeal under 28 U.S.C. § 158(d)(2). In re Whittaker, Clark & Daniels, 663 B.R. 1 (Bankr. D.N.J. 2024).
• U.S. District Court, District of New Jersey (Judge Zahid N. Quraishi). Affirmed the bankruptcy-authority ruling for substantially the same reasons.
• U.S. Court of Appeals for the Third Circuit. The consolidated appeals — brought by Protopapas (No. 24-2210) and the Official Committee of Talc Claimants (No. 24-2211), with the Brenntag adversary proceeding at No. 25-1044 — were argued, reheard, and resolved in the precedential opinion filed April 27, 2026.

What did the Third Circuit hold?

The court affirmed, resolving the appeal on three points:

1. An improperly filed bankruptcy petition is not jurisdictional. An unauthorized petition is "cause" to dismiss under 11 U.S.C. § 1112(b), but it does not strip the bankruptcy court of subject-matter jurisdiction. The court aligned with the Second and Ninth Circuits on this previously unsettled question.
2. Whittaker's board properly filed for bankruptcy. The South Carolina receivership order did not — and could not, consistent with corporate-governance principles — displace the board's authority to authorize a bankruptcy filing; displacing the board would have required ancillary receivership proceedings in New Jersey.
3. Product-line successor-liability claims are property of the estate under § 541. The claims talc claimants sought to assert against Brenntag belong to the Debtors' bankruptcy estates, applying and extending In re Emoral, 740 F.3d 875 (3d Cir. 2014), and In re Wilton Armetale, 968 F.3d 273 (3d Cir. 2020). Because those claims are estate property, the trustee/debtor-in-possession has exclusive authority to pursue, settle, and release them under 11 U.S.C. § 323.

The court declined to reach the bankruptcy court's alternative grounds (11 U.S.C. §§ 541(a)(7) and 544(a)(1)) because the § 541(a)(1) analysis was dispositive.

What does the ruling mean for talc-asbestos claimants?

The decision is best understood as centralizing recovery rather than ending it. Because the product-line claims are estate property, individual claimants can no longer separately prosecute or settle those particular claims against Brenntag — but the practical upside is that the $535 million Brenntag settlement is preserved and channeled into the estate, where it forms a recovery pool to be distributed to creditors, including asbestos victims, often a larger and more orderly source of compensation than scattered individual suits.

Two features of the opinion matter for claimants going forward. The court rejected the idea that plaintiffs can "plead around" the bankruptcy by recasting estate claims as personal ones, quoting In re Tronox, 855 F.3d 84 (2d Cir. 2017). But it also held that the Committee's objection under Harrington v. Purdue Pharma L.P., 603 U.S. 204 (2024) — that treating the claims as estate property and releasing them would amount to a barred non-consensual third-party release — was premature, not meritless: that argument can be raised at the plan-confirmation stage, leaving claimants an avenue to be heard as the case proceeds. Finally, the "product-line" successor-liability theory is recognized in only a minority of states (the court named New Jersey and California), and neither court resolved how many claimants held cognizable product-line claims — a question that bears on the ruling's ultimate reach.

If you or a family member has a talc-asbestos or mesothelioma claim touched by a corporate bankruptcy like this one, the path to compensation runs through the estate and any future trust — and the deadlines and procedures are unforgiving. Experienced asbestos counsel can preserve your place in that process.

How does this connect to asbestos bankruptcy trusts?

The opinion does not itself establish or administer a formal asbestos trust under 11 U.S.C. § 524(g) — the mechanism Congress created to channel asbestos claims through a dedicated trust. The Whittaker matter is an ordinary Chapter 11 case, and whether the $535 million is ultimately distributed through a § 524(g) channeling trust or a conventional Chapter 11 plan will be decided in later proceedings. The Official Committee of Talc Claimants — the statutory representative of talc creditors — will continue to represent claimants' interests as that distribution structure is built. For background on how these trusts pay victims, see Asbestos Trust Funds.

What this means for patients and families

In plain terms: when a company responsible for asbestos exposure goes bankrupt, the law often gathers the related claims together so that one large settlement can be shared fairly among everyone harmed, instead of a few early plaintiffs collecting while later victims get nothing. Here, that means the $535 million Brenntag settlement is protected and headed toward the people who were hurt — but it also means recovery happens through the bankruptcy estate and any future trust, on the court's schedule, not through a standalone lawsuit against the buyer.

A few practical takeaways:

• Your claim still has value. Being routed through a bankruptcy estate or trust is a normal, established path to compensation, not a dead end.
• Deadlines are strict. Bankruptcy bar dates and trust filing deadlines are separate from court statutes of limitations and can come quickly.
• Documentation matters. Diagnosis records, work and product-exposure history, and proof of which products caused exposure all strengthen a claim.
• Counsel matters. These cases turn on procedure — who controls the claim, which deadline applies, how the trust distributes — where experienced asbestos attorneys add the most value.

Frequently Asked Questions

Did talc-asbestos victims lose their claims in this ruling? No. The Third Circuit held that certain successor-liability claims against Brenntag belong to the bankruptcy estate rather than to individuals — which preserves the $535 million Brenntag settlement and channels it to victims through the estate, rather than extinguishing recovery.

What is the $535 million settlement? Brenntag, which bought Whittaker's assets in 2004, agreed to pay approximately $535 million to the Debtors' estate in exchange for release of successor-liability claims. The Third Circuit's ruling clears the way for that settlement to fund distributions to claimants.

What is "product-line successor liability"? It is a theory under which a company that buys another's product line can be held responsible for injuries caused by the predecessor's products. The court held these particular claims are property of the bankruptcy estate, so the trustee — not individual plaintiffs — controls them. The theory is recognized in only a minority of states.

Can claimants still object as the case continues? Yes. The court left open the Purdue Pharma argument about non-consensual third-party releases for the plan-confirmation stage, preserving an avenue for claimant objections later in the bankruptcy.

Is this the same as a § 524(g) asbestos trust? Not yet. The opinion does not create a § 524(g) trust; whether one is established will be decided in future proceedings. See Asbestos Trust Funds for how such trusts work.

Quick Statistics

• April 27, 2026 — date of the precedential Third Circuit opinion.
• ~2,700 — asbestos personal-injury claimants against the Debtors.
• $535 million — Brenntag settlement preserved by the ruling.
• $29 million — Sarah Plant's 2023 South Carolina mesothelioma verdict.
• ~$200 million — 2004 Brenntag asset purchase price.
• 14+ — states touched by environmental claims.
• 3 — consolidated docket numbers (24-2210, 24-2211, 25-1044).

External Links

If you or a loved one was diagnosed with mesothelioma or another asbestos-related disease from talc exposure, your right to compensation can be affected by corporate bankruptcies like this one — and the deadlines are strict. The attorneys at Danziger & De Llano offer free, no-obligation consultations and help families pursue every available avenue, including asbestos trust claims and civil litigation. Learn more at the Mesothelioma Lawyer Center. Call (855) 699-5441 to speak with someone today.

Related Pages

• Asbestos Trust Funds
• Talc and Mesothelioma
• Mesothelioma Lawsuit
• Asbestos Bankruptcy Trusts
• Mesothelioma Settlements and Verdicts